The network meta-analytic-predictive approach to non-inferiority trials (Q43884253)

27 November 2017

title

The network meta-analytic-predictive approach to non-inferiority trials (English)

1 reference

27 November 2017

1 reference

Beat Neuenschwander

3

0 references

author name string

Heinz Schmidli

series ordinal

1

1 reference

27 November 2017

Simon Wandel

series ordinal

2

1 reference

27 November 2017

publication date

4 January 2012

1 reference

Statistical Methods in Medical Research

27 November 2017

published in

1 reference

27 November 2017

volume

22

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

219-240

1 reference

Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

The European regulatory experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Trials to assess equivalence: the importance of rigorous methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

A re-evaluation of random-effects meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Borrowing strength from external trials in a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Combination of direct and indirect evidence in mixed treatment comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Evaluation of networks of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Bayesian design and analysis of active control clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Stroke prevention--insights from incoherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Digestion of the antiplatelets comparison of PRoFESS: 18-7=1?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Meta-analysis of mixed treatment comparisons at multiple follow-up times.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

The combination of randomized and historical controls in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Tutorial in biostatistics. Meta-analysis: formulating, evaluating, combining, and reporting by S-L. T. Normand, Statistics in Medicine, 18, 321-359 (1999)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Advanced methods in meta-analysis: multivariate approach and meta-regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Summarizing historical information on controls in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

An informed reference prior for between-study heterogeneity in meta-analyses of binary outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Sampling-Based Approaches to Calculating Marginal Densities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Active-control trials: how would a new agent compare with placebo? A method illustrated with clopidogrel, aspirin, and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

The use of putative placebo in active control trials: two applications in a regulatory setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Design and analysis of non-inferiority mortality trials in oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Network meta-analysis of survival data with fractional polynomials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Designing a non-inferiority study in kidney transplantation: a case study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Checking consistency in mixed treatment comparison meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Another view of active-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Bayesian measures of model complexity and fit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

Using mixed treatment comparisons and meta-regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432512

21 January 2018

Identifiers

DOI

10.1177/0962280211432512

1 reference

release_2t26jljktba4lk5plpjl3rm4ku

27 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2t26jljktba4lk5plpjl3rm4ku

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference